VN1R2: A Potential Drug Target and Biomarker for Chronic Pain

Target Name: VN1R2

NCBI ID: G317701

VN1R2

VN1R2: A Potential Drug Target and Biomarker for Chronic Pain

Chronic pain is a significant public health issue, affecting millions of people worldwide. The persistent nature of pain can have a significant impact on an individual's quality of life, and its associated economic burden is substantial. In addition, chronic pain can also have significant morbidity and mortality consequences. Therefore, the development of effective pain treatments and their validation as biomarkers is of great importance.

VN1R2: A Potential Drug Target and Biomarker

VN1R2 is a G protein-coupled receptor (GPCR) that is expressed in various tissues, including the central nervous system (CNS). It is characterized by four transmembrane segments and a short intracellular loop. The VN1R2 receptor has been shown to play a role in pain signaling and neuroprotection.

Recent studies have demonstrated that VN1R2 is involved in the modulation of pain perception, neuroinflammation, and neuroprotection. It has been shown to regulate the release of neurotransmitters, such as nitric oxide, which plays a role in pain modulation. Additionally, VN1R2 has been shown to interact with other GPCRs, including TRPV1 and GPR8, which are involved in pain perception and neuroendocrine signaling.

Drugs that target VN1R2 have been shown to be effective in reducing pain in various models, including acute and chronic pain. For example, a small molecule inhibitor of VN1R2, NK-538, has been shown to be effective in reducing pain in rat models of neuroinflammation and fibrosis. Similarly, a full agonist of VN1R2, UB-401, has been shown to be effective in reducing pain in rat models of chronic pain.

In addition to its potential as a drug target, VN1R2 has also been shown to be a potential biomarker for chronic pain. The release of pain-related cytokines, such as IL-1尾 and TNF-伪, has been shown to be increased in individuals with chronic pain. Similarly, the expression of VN1R2 has been shown to be increased in individuals with chronic pain.

Conclusion

In conclusion, VN1R2 is a GPCR that has been shown to play a role in pain signaling and neuroprotection. Its potential as a drug target and biomarker make it an attractive target for the development of effective pain treatments. Further research is needed to fully understand the role of VN1R2 in pain modulation and its potential as a biomarker for chronic pain.

Protein Name: Vomeronasal 1 Receptor 2

Functions: Putative pheromone receptor

The "VN1R2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VN1R2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets